The Extended Gestational Age Medical Abortion Study

Completed · Phase 4

Conditions studied: Medical Abortion

In brief

This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 days' versus 64-70 days' gestation.

Key facts

Study ID: NCT00997347
Run by: Gynuity Health Projects
People needed: 1400
Starts: 2009-07-01
Expected to finish: 2012-02-01
Last updated by the study team: 2012-07-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

intrauterine pregnancy of greater than 56 days and less than 71 days
eligible for medical abortion according to study doctor assessment
willing and able to sign consent forms
speak English or Spanish (in US sites); speak the local language(s) (in international sites)
agree to comply with the study procedures and visit schedule

Where it is running

Presidential Women's Center — West Palm Beach, Florida, United States
Family Planning Associates Medical Group — Chicago, Illinois, United States
Planned Parenthood League of Massachusetts — Boston, Massachusetts, United States
Planned Parenthood, Minnesota, North Dakota, South Dakota — Saint Paul, Minnesota, United States
Planned Parenthood of New York City — New York, New York, United States
Planned Parenthood, Central Texas — Waco, Texas, United States
Zhordania Institute of Human Reproduction — Tbilisi, Georgia
Government Medical College (GMC) — Nagpur, India
Naval Nursing Home — Solapur, India
La Rabta Maternity Hospital — Tunis, Tunisia
Central District Maternity House — Odesa, Ukraine
Maternity Hospital No.2 — Simferopol, Ukraine

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.